R & D

Keeping in view Hemarus’s commitment to innovate for life, the R&D team continuously strives to develop processes to produce the highest quality products using most advanced state-of-the-art technologies in the field. Plasma derivatives are manufactured using end-to-end advanced chromatography based processes as opposed to the older technology using Cohn’s precipitation techniques. Viral safety is ensured by the incorporation of multiple orthogonal viral inactivation and removal steps in the process. The plasma derivatives manufactured by Hemarus conforms or exceed the most stringent international standards for safety and efficacy of plasma derivatives.

Scientists at Hemarus are actively engaged in a wide variety of projects ranging from development of new plasma products, new formulations to identifying new targets for therapeutic intervention.

Hemarus Therapeutics
Website Hit Counters
 
Copyrights © Hemarus. All Rights Reserved. Home R & D Manufacturing Products Board Careers Plasma Collection Contact Us